1. Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
   Jianwei Feng et al, 2022, Frontiers in Pharmacology CrossRef
2. Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer
   Qin Liu et al, 2021, Aging CrossRef
3. Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
   Yan Zhao et al, 2021, Frontiers in Oncology CrossRef
4. Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
   Hao Lei et al, 2021, Journal of Medicinal Chemistry CrossRef
5. Current progress of ferroptosis study in ovarian cancer
   Zhuomin Tan et al, 2022, Frontiers in Molecular Biosciences CrossRef
6. Advancement in understanding the role of ferroptosis in rheumatoid arthritis
   Li Long et al, 2022, Frontiers in Physiology CrossRef
7. “Double-Edged Sword” Effect of Reactive Oxygen Species (ROS) in Tumor Development and Carcinogenesis
   W Zhao et al, 2023, Physiological Research CrossRef
8. A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia
   Han Gong et al, 2022, BioMed Research International CrossRef
9. The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer
   Biqing Chen et al, 2023, Frontiers in Genetics CrossRef
10. Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
    Danhua Ruan et al, 2023, Cell Death Discovery CrossRef
11. ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative
    Amanda B. Kagan et al, 2023, Cancer Chemotherapy and Pharmacology CrossRef
12. Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential
    Chuchu Xu et al, 2023, Frontiers in Pharmacology CrossRef